Knueppel P, Bang SH, Troyer C, Barriga A, et al. Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE). Thromb Res 2022;220:91-96.
PMID: 36306678